Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> D >> (alphaS)-1,4-Dihydro-alpha-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide

(alphaS)-1,4-Dihydro-alpha-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide
[CAS# 672926-33-9]

List of Suppliers
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Complete supplier list of (alphaS)-1,4-Dihydro-alpha-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide
Identification
Name (alphaS)-1,4-Dihydro-alpha-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide
Synonyms Kif15-IN-2
Molecular Structure CAS # 672926-33-9, (alphaS)-1,4-Dihydro-alpha-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide, Kif15-IN-2
Molecular Formula C20H20N6O4S
Molecular Weight 440.48
CAS Registry Number 672926-33-9
Properties
Solubility Insoluble (3.1E-3 g/L) (25 ºC), Calc.*
Density 1.409±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Market Analysis Reports
List of Reports Available for (alphaS)-1,4-Dihydro-alpha-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide
Related Products
1a,7a-Dihydro-1a-(3-methyl-2-butenyl)naphth[2,3-b]oxirene-2,7-dione  4,5-Dihydro-2-[(3-methyl-2-buten-1-yl)thio]thiazole  6,7-Dihydro-5-methyl-5(H)-cyclopentapyrazine  5,7-Dihydro-5-methyl-6H-dibenz[b,d]azepin-6-one  N-(5,11-Dihydro-5-methyl-10H-dibenz[b,f]azepin-10-ylidene)-methanamine ethanedioate (1:1)  2-[[3,4-Dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-piperidinylamino]-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile  N-[2-(3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine  4,5-Dihydro-5-methyl-3,4-diphenyl-5-isoxazolol  5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one  1,3-Dihydro-1-(1-methylethenyl)-2H-benzimidazole-2-one  (2R)-1-[(4R)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-(diphenylphosphino)ferrocene  (2R)-1-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-(diphenylphosphino)ferrocene  (2S)-1-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-(diphenylphosphino)ferrocene  (2S)-1-[(4R)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-(diphenylphosphino)ferrocene  4,7-Dihydro-6-(1-methylethyl)-7-oxo-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile  1,2-Dihydro-4-(1-methylethyl)-2-oxo-3-quinolinecarboxylic acid methyl ester  2,3-Dihydro-2-(1-methylethyl)-4-phenyl-1H-inden-1-one  1,3-Dihydro-1-[[4-(1-methylethyl)phenyl]methyl]-2H-benzimidazol-2-one  2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one  2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl-2,2,3,3,3-d5)-3H-1,2,4-triazol-3-one